These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2944028)

  • 1. Hypertension and tachycardia produced by inhibition of reuptake of 5-hydroxytryptamine by fluoxetine in the rat.
    Tsai ML; Lin MT
    Neuropharmacology; 1986 Jul; 25(7):799-802. PubMed ID: 2944028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 5-hydroxytryptamine, fluoxetine and chlorimipramine on reflex bradycardia in rats.
    Lin MT; Tsay BL; Fan YC
    J Pharm Pharmacol; 1980 Jul; 32(7):493-6. PubMed ID: 6105186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent.
    Persson B; Hedner T; Henning M
    J Pharm Pharmacol; 1982 Jul; 34(7):442-5. PubMed ID: 6126541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors.
    Saxena PR; Mylecharane EJ; Heiligers J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):121-9. PubMed ID: 2931607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pineal stimulation produces both hypertension and tachycardia in rats.
    Chuang JI; Lin MT
    Brain Res Bull; 1994; 33(5):473-6. PubMed ID: 8186991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fluoxetine, a serotonin reuptake inhibitor, on the pituitary-thyroid axis in rat.
    Golstein J; Schreiber S; Velkeniers B; Vanhaelst L
    Eur J Pharmacol; 1983 Jul; 91(2-3):239-43. PubMed ID: 6413229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by intraventricular microinfusion of ketanserin of the cardiovascular responses to peripheral administration of methoxamine in rats.
    Mollace V; De Francesco EA; Fersini G; Nisticò G
    Funct Neurol; 1991; 6(2):101-6. PubMed ID: 1655588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subsensitivity of serotonin receptors after long-term treatment of rats with fluoxetine.
    Wong DT; Bymaster FP
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):41-51. PubMed ID: 6974884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenaline release in the rat vena cava and in the heart of the pithed rat.
    Göthert M; Schlicker E; Kollecker P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):124-30. PubMed ID: 2939353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological studies on the serotoninergic and nonserotonin-mediated stimulation of prolactin and corticosterone secretion by fenfluramine. Effects of pretreatment with fluoxetine, indalpine, PCPA, and L-tryptophan.
    Van de Kar LD; Urban JH; Richardson KD; Bethea CL
    Neuroendocrinology; 1985 Oct; 41(4):283-8. PubMed ID: 2931613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats.
    Kalkman HO; Engel G; Hoyer D
    J Hypertens Suppl; 1984 Dec; 2(3):S143-5. PubMed ID: 6599662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of chronic 5-hydroxytryptamine (5-HT2) receptor blockade with ketanserin in the spontaneously hypertensive rat.
    Pettersson A; Persson B; Henning M; Hedner T
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):43-7. PubMed ID: 6493349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catabolism of intracerebroventricularly injected 5-hydroxytryptamine in mouse: effect of coinjection of tryptamine and several pretreatments.
    Sloley BD; Orikasa S; Boulton AA
    Can J Physiol Pharmacol; 1993; 71(3-4):201-4. PubMed ID: 8402383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for an alpha-1 receptor-mediated central sympathoinhibitory action of ketanserin.
    McCall RB; Schuette MR
    J Pharmacol Exp Ther; 1984 Mar; 228(3):704-10. PubMed ID: 6323678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacologic profile of fluoxetine.
    Stark P; Fuller RW; Wong DT
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of a bulbospinal serotonergic pathway in the rat brain in clonidine-induced hypotension and bradycardia.
    Tsai ML; Lin MT
    Pharmacology; 1987; 35(5):279-85. PubMed ID: 3423103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tachycardia, hypertension and decreased reflex bradycardia produced by striatal lesions induced by kainic acid.
    Wu JJ; Shih CJ; Lin MT
    Neuropharmacology; 1984 Nov; 23(11):1231-5. PubMed ID: 6527735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Carboxamidotryptamine is a selective agonist at 5-hydroxytryptamine receptors mediating vasodilatation and tachycardia in anaesthetized cats.
    Connor HE; Feniuk W; Humphrey PP; Perren MJ
    Br J Pharmacol; 1986 Feb; 87(2):417-26. PubMed ID: 2937503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic mechanisms and blood pressure in sheep.
    Nelson MA; Coghlan JP; Denton DA; Mills EH; Scoggins BA; Spence CD; Whitworth JA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S117-9. PubMed ID: 2412029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.